재정 지원 요구사항을 통해 공개된 자료 - Sandra Gemma자세히 알아보기
제공된 곳이 없음: 29
Old but gold: tracking the new guise of histone deacetylase 6 (HDAC6) enzyme as a biomarker and therapeutic target in rare diseases
M Brindisi, AP Saraswati, S Brogi, S Gemma, S Butini, G Campiani
Journal of medicinal chemistry 63 (1), 23-39, 2019
재정 지원 요구사항 정책: Department of Biotechnology, India, Government of Italy
Modulation of the innate immune response by targeting toll-like receptors: a perspective on their agonists and antagonists
S Federico, L Pozzetti, A Papa, G Carullo, S Gemma, S Butini, ...
Journal of Medicinal Chemistry 63 (22), 13466-13513, 2020
재정 지원 요구사항 정책: Department of Biotechnology, India, Government of Italy
Polypharmacology of dopamine receptor ligands
S Butini, K Nikolic, S Kassel, H Brückmann, S Filipic, D Agbaba, S Gemma, ...
Progress in neurobiology 142, 68-103, 2016
재정 지원 요구사항 정책: German Research Foundation, European Commission
Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas
T Khan, N Relitti, M Brindisi, S Magnano, D Zisterer, S Gemma, S Butini, ...
Medicinal Research Reviews 40 (3), 1002-1060, 2020
재정 지원 요구사항 정책: European Commission
Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agents
S Gemma, C Camodeca, M Brindisi, S Brogi, G Kukreja, S Kunjir, ...
Journal of medicinal chemistry 55 (23), 10387-10404, 2012
재정 지원 요구사항 정책: National Health and Medical Research Council, Australia
Optimization of 4-aminoquinoline/clotrimazole-based hybrid antimalarials: Further structure–activity relationships, in vivo studies, and preliminary toxicity profiling
S Gemma, C Camodeca, S Sanna Coccone, BP Joshi, M Bernetti, ...
Journal of medicinal chemistry 55 (15), 6948-6967, 2012
재정 지원 요구사항 정책: National Health and Medical Research Council, Australia
Rational design of the first difluorostatone-based PfSUB1 inhibitors
S Giovani, M Penzo, S Brogi, M Brindisi, S Gemma, E Novellino, L Savini, ...
Bioorganic & Medicinal Chemistry Letters 24 (15), 3582-3586, 2014
재정 지원 요구사항 정책: UK Medical Research Council, Government of Italy
Telomerase-based cancer therapeutics: a review on their clinical trials
N Relitti, AP Saraswati, S Federico, T Khan, M Brindisi, D Zisterer, S Brogi, ...
Current Topics in Medicinal Chemistry 20 (6), 433-457, 2020
재정 지원 요구사항 정책: European Commission
Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors
AP Saraswati, N Relitti, M Brindisi, S Gemma, D Zisterer, S Butini, ...
Drug Discovery Today 24 (7), 1370-1388, 2019
재정 지원 요구사항 정책: European Commission
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigation
N Relitti, AP Saraswati, G Chemi, M Brindisi, S Brogi, D Herp, ...
European Journal of Medicinal Chemistry 212, 112998, 2021
재정 지원 요구사항 정책: European Commission, Government of Italy
Screening and Phenotypical Characterization of Schistosoma mansoni Histone Deacetylase 8 (SmHDAC8) Inhibitors as Multistage Antischistosomal Agents
F Saccoccia, M Brindisi, R Gimmelli, N Relitti, A Guidi, AP Saraswati, ...
ACS Infectious Diseases 6 (1), 100-113, 2019
재정 지원 요구사항 정책: German Research Foundation, European Commission, Government of Italy
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies
M Brindisi, C Cavella, S Brogi, A Nebbioso, J Senger, S Maramai, A Ciotta, ...
Future Medicinal Chemistry 8 (13), 1573-1587, 2016
재정 지원 요구사항 정책: German Research Foundation, European Commission, Government of Italy
A stereoselective approach to peptidomimetic BACE1 inhibitors
S Butini, E Gabellieri, M Brindisi, S Giovani, S Maramai, G Kshirsagar, ...
European Journal of Medicinal Chemistry 70, 233-247, 2013
재정 지원 요구사항 정책: Government of Italy
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability
S Federico, T Khan, A Fontana, S Brogi, R Benedetti, F Sarno, G Carullo, ...
European journal of medicinal chemistry 238, 114409, 2022
재정 지원 요구사항 정책: Department of Biotechnology, India, Government of Italy, AIRC Foundation for …
Retinitis pigmentosa and retinal degenerations: Deciphering pathways and targets for drug discovery and development
G Carullo, S Federico, N Relitti, S Gemma, S Butini, G Campiani
ACS chemical neuroscience 11 (15), 2173-2191, 2020
재정 지원 요구사항 정책: Department of Biotechnology, India, Government of Italy
Dealing with schistosomiasis: Current drug discovery strategies
S Gemma, S Federico, S Brogi, M Brindisi, S Butini, G Campiani
Annual Reports in Medicinal Chemistry 53, 107-138, 2019
재정 지원 요구사항 정책: Government of Italy
Unconventional Knoevenagel-type indoles: Synthesis and cell-based studies for the identification of pro-apoptotic agents
A Spallarossa, C Caneva, M Caviglia, S Alfei, S Butini, G Campiani, ...
European Journal of Medicinal Chemistry 102, 648-660, 2015
재정 지원 요구사항 정책: Government of Italy
From (+)-epigallocatechin gallate to a simplified synthetic analogue as a cytoadherence inhibitor for P. falciparum
S Gemma, S Brogi, PR Patil, S Giovani, S Lamponi, A Cappelli, ...
Rsc Advances 4 (9), 4769-4781, 2014
재정 지원 요구사항 정책: Government of Italy
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions
A Papa, S Pasquini, F Galvani, M Cammarota, C Contri, G Carullo, ...
European Journal of Medicinal Chemistry 246, 114952, 2023
재정 지원 요구사항 정책: Government of Italy
Synthesis of Unsymmetrical Squaramides as Allosteric GSK‐3β Inhibitors Promoting β‐Catenin‐Mediated Transcription of TCF/LEF in Retinal Pigment Epithelial Cells
G Carullo, L Bottoni, S Pasquini, A Papa, C Contri, S Brogi, V Calderone, ...
ChemMedChem 17 (24), e202200456, 2022
재정 지원 요구사항 정책: Government of Italy
발행인 및 자금 지원 정보는 컴퓨터 프로그램에서 자동으로 결정됩니다.